Sangamo Therapeutics
SGMO
#8725
Rank
NZ$0.28 B
Marketcap
NZ$0.86
Share price
-6.45%
Change (1 day)
-75.06%
Change (1 year)

Sangamo Therapeutics (SGMO) - Total assets

Total assets on the balance sheet as of September 2025 : NZ$0.15 Billion

According to Sangamo Therapeutics 's latest financial reports the company's total assets are NZ$0.15 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Sangamo Therapeutics - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31NZ$0.18 B-31.06%
2023-12-31NZ$0.26 B-70.49%
2022-12-31NZ$0.88 B-16.17%
2021-12-31NZ$1.05 B-18.75%
2020-12-31NZ$1.30 B37.41%
2019-12-31NZ$0.94 B7.55%
2018-12-31NZ$0.88 B118%
2017-12-31NZ$0.40 B77.13%
2016-12-31NZ$0.22 B-28.19%
2015-12-31NZ$0.31 B2.25%
2014-12-31NZ$0.31 B81.12%
2013-12-31NZ$0.17 B70.83%
2012-12-31NZ$0.10 B-10.35%
2011-12-31NZ$0.11 B37.04%
2010-12-31NZ$81.65 M-32.17%
2009-12-31NZ$0.12 B2.97%
2008-12-31NZ$0.11 B6.74%
2007-12-31NZ$0.10 B38.34%
2006-12-31NZ$79.17 M10.48%
2005-12-31NZ$71.66 M47.26%
2004-12-31NZ$48.66 M-31.57%
2003-12-31NZ$71.12 M-33.8%
2002-12-31NZ$0.10 B-47.52%
2001-12-31NZ$0.20 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Gilead Sciences
GILD
NZ$101.32 B 65,932.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$8.39 B 5,373.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$156.03 B 101,589.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$50.55 B 32,849.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
NZ$105.57 B 68,704.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$333.76 B 217,419.71%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$13.18 B 8,490.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$224.24 B 146,043.52%๐Ÿ‡บ๐Ÿ‡ธ USA